Salmoporc, lyofilizát a rozpúšťadlo na injekčnú suspenziu pre ošípané Slovakien - slovakiska - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

salmoporc, lyofilizát a rozpúšťadlo na injekčnú suspenziu pre ošípané

ceva animal health slovakia, slovenská republika - inj.

Salmoporc, lyofilizát na orálnu suspenziu pre ošípané Slovakien - slovakiska - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

salmoporc, lyofilizát na orálnu suspenziu pre ošípané

ceva animal health slovakia, slovenská republika - oral susp.

Ciclosporin Sandoz 100 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ciclosporin sandoz 100 mg

sandoz pharmaceuticals d.d., slovinsko - cyklosporín - 59 - immunopraeparata

Ciclosporin Sandoz 50 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ciclosporin sandoz 50 mg

sandoz pharmaceuticals d.d., slovinsko - cyklosporín - 59 - immunopraeparata

Ciclosporin Sandoz 25 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ciclosporin sandoz 25 mg

sandoz pharmaceuticals d.d., slovinsko - cyklosporín - 59 - immunopraeparata

Sandimmun Neoral 100 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandimmun neoral 100 mg

novartis slovakia s.r.o., slovensko - cyklosporín - 59 - immunopraeparata

Sandimmun Neoral 50 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandimmun neoral 50 mg

novartis slovakia s.r.o., slovensko - cyklosporín - 59 - immunopraeparata

Insulin aspart Sanofi Europeiska unionen - slovakiska - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - inzulín aspart - cukrovka - lieky používané pri cukrovke - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Onureg Europeiska unionen - slovakiska - EMA (European Medicines Agency)

onureg

bristol-myers squibb pharma eeig - azacitidín - leukémia, myeloidná, akútna - antineoplastické činidlá - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Bimzelx Europeiska unionen - slovakiska - EMA (European Medicines Agency)

bimzelx

ucb pharma s.a.   - bimekizumab - svrab - imunosupresíva - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.